Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control
| Autor: | Vallejo-Vaz, Antonio J., Ray, Kausik K., Ginsberg, Henry N., Davidson, Michael H., Eckel, Robert H., Lee, L. Veronica, Bessac, Laurence, Pordy, Robert, Letierce, Alexia, Cannon, Christopher P. |
|---|---|
| Zdroj: | In Atherosclerosis September 2019 288:85-93 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect